Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Rang în acțiuni #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Preț acțiune
$0.00185055
Capitalizare de piață
$48.29K
Schimbare (1 zi)
-3.55%
Schimbare (1 an)
30.31%
Țară
GB
Tranzacționează Nuformix plc (NFX)

Categorie

Raport P/S pentru Nuformix plc (NFX)
Raport P/S la data de September 2026 TTM: 0.00
Conform celor mai recente rapoarte financiare și prețului acțiunilor Nuformix plc, raportul P/S actual (TTM) este 0.00. La sfârșitul anului 2024, compania avea un P/S de 0.00.
Istoricul raportului P/S pentru Nuformix plc din 2014 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
2026 (TTM) 0.00 0.00%
2025 0.00 0.00%
2024 0.00 0.00%
2023 0.00 -100.00%
2022 116.70 74.68%
2021 66.81 87.30%
2020 35.67 81.62%
2019 19.64 -95.96%
2018 485.61 0.00%
2017 0.00 -100.00%
2016 2.23 0.00%
2014 0.00 0.00%
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
10.44 -
US
26.12 -
US
3.76 -
AU
12.01 -
NL
- -
CH